Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Truist Securities Downgrades MEI Pharma to Hold

Truist Securities analyst Robyn Karnauskas downgrades MEI Pharma (NASDAQ:MEIP) from Buy to Hold.
byBenzinga Newsdesk
December 6, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Truist Securities analyst Robyn Karnauskas downgrades MEI Pharma (NASDAQ:MEIP) from Buy to Hold.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts